GlassScriptPhysician profile
Idalmis M Rodriguez
NPI 1841264728
$913.57
in general payments reported to CMS, 2019-2025
11 companies · $211 in 2025
The $211 reported for 2025 was more than what 76% of Registered Nurse providers received nationally (typical 2025 total: $73.55).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $29.04 · 2022: $372 · 2023: $94.39 · 2024: $207 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $435 · Education: $76.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $435.13 |
| Education | $76.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $243.88 | 2021-2022 | |
| Astellas Pharma US INC | $193.94 | 2024-2025 | Veozah |
| Agile Therapeutics, INC. | $91.12 | 2022-2024 | Twirla |
| Hologic Sales and Service, LLC | $81.66 | 2022-2024 | Myosure Tissue Removal Device, Novasure, Aptima |
| Shield Therapeutics INC | $66.28 | 2024-2025 | |
| Mayne Pharma Commercial LLC | $64.72 | 2022-2025 | |
| Exeltis, USA INC. | $60.25 | 2022-2025 | Slynd |
| Sumitomo Pharma America, INC. | $50.86 | 2023-2024 | Myfembree, Gemtesa |
| Pfizer INC. | $22.67 | 2025 | |
| Scynexis, INC. | $21.87 | 2022 | |
| Medtronic, INC. | $16.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Idalmis Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.